Aditxt (NASDAQ: ADTX), a global innovation company focused on developing and commercializing technologies that monitor and modulate the immune system, will be participating in the 25th annual H.C. Wainwright Global Investment Conference; the premier event is scheduled for Sept. 11–13, 2023, in New York City. According to the announcement, Aditxt chair, cofounder and CEO Amro Albanna will present during the conference; his presentation is scheduled for Sept. 13 at 4:30 p.m. EST. During his presentation, he will provide key information about Aditxt. Members of the Aditxt team will also be available during the three-day event for one-on-one meetings.
To view the presentation, visit https://ibn.fm/ldGuA
To view the full press release, visit https://ibn.fm/e9Nkg
About Aditxt Inc.
Aditxt is a global innovation company focused on discovering and developing precision medicine innovations and deploying them into high-performing businesses. The company is headquartered in Richmond, Virginia, with operations in Mountain View, California, and Melville, New York. Aditxt’s mission of “Making Promising Innovations Possible, Together” is defined by its growing ecosystem of research institutions, global industry partners and shareholders who inform and inspire that mission. Aditxt’s diverse innovation portfolio includes: Adimune(TM) Inc., which is focused on developing and designing a new class of therapeutics for retraining the immune system to address organ rejection, autoimmunity and allergies; Adivir(TM) Inc., which is focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta(TM) Inc., which offers convenient, rapid, personalized and high-quality lab testing. For more information, please visit www.Aditxt.com and www.AditxtScore.com.
NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
